Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data

Kidney and Blood Pressure Research

Volumn 37, Issue 4-5, 2013, Pages 346-359

  Salmhofer, Hermann ^a,b   Franzen, Michael ^a,b   Hitzl, Wolfgang ^c   Koller, Josef ^c   Kreymann, Bernhard ^b   Fend, Falko ^b   Hauser Kronberger, Cornelia ^c   Heemann, Uwe ^b   Berr, Frieder ^a   Schmaderer, Christoph ^b  

^a Leitung Ltd   (Austria)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Calcific uremic arteriolopathy; Calciphylaxis; Cinacalcet; End stage renal disease; Hyperparathyroidism; Sevelamer; Sodium thiosulfate

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; BICARBONATE; CALCITONIN; CALCITRIOL; CALCIUM CARBONATE; CINACALCET; FUROSEMIDE; HEPARIN; HYPERTENSIVE AGENT; IBANDRONIC ACID; METOCLOPRAMIDE; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; SEVELAMER; SODIUM THIOSULFATE; WARFARIN; CALCIUM; HYPERTENSIVE FACTOR;

ABSCESS DRAINAGE; ACIDOSIS; ADULT; AGED; ANALGESIC ACTIVITY; ANOREXIA; ANTIBIOTIC THERAPY; AORTA VALVE DISEASE; AORTIC VALVE THROMBOSIS; ARTICLE; CALCINOSIS; CASE STUDY; CLINICAL ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYSIPELAS; GASTRIC ULCER BLEEDING; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; HYPERNATREMIA; HYPERPARATHYROIDISM; INFECTION; INTENSIVE CARE; KIDNEY FAILURE; LEG ULCER; MAINTENANCE DRUG DOSE; MALE; METABOLIC ACIDOSIS; NAUSEA; OUTCOME ASSESSMENT; PAIN; PARATHYROIDECTOMY; PATIENT COMPLIANCE; POLYPHARMACY; PRIORITY JOURNAL; PRURITUS; SEIZURE; SEPSIS; SKIN BIOPSY; SKIN INDURATION; SKIN INFECTION; SKIN NECROSIS; SOFT TISSUE INFECTION; SURVIVAL; THROMBOSIS; TREATMENT REFUSAL; ULCER HEALING; VOMITING; WOUND CARE; WOUND HEALING; ABDOMINAL PAIN; ABDOMINAL SUBCUTANEOUS FAT; ANALGESIA; AORTA THROMBOSIS; ARTIFICIAL VENTILATION; CALCIUM BLOOD LEVEL; CONTINUOUS INFUSION; END STAGE RENAL DISEASE; ENDOCARDITIS; FEMALE; GENERAL CONDITION IMPROVEMENT; IMMOBILIZATION; LONG TERM CARE; MEDICATION COMPLIANCE; MIDDLE AGED; MITRAL VALVE REPLACEMENT; NAUSEA AND VOMITING; PAIN ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERICARDIAL EFFUSION; PNEUMONIA; POST TREATMENT SURVIVAL; SECONDARY INFECTION; SUDDEN CARDIAC DEATH; TREATMENT DURATION;

AGED; CALCIPHYLAXIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; POLYAMINES; THIOSULFATES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84890361818     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000350162     Document Type: Article

References (47)

1. Brandenburg VM, Kramann R, Specht P, Ketteler M: Calciphylaxis in CKD and beyond. Nephrol Dial Transplant 2012;27:1314-1318
2. Asobie N, Wong E, Cook MG: Calciphylaxis in a diabetic patient provoked by warfarin therapy. Clin Exp Dermatol 2008;33:342-344
3. Nigwekar SU, Wolf M, Sterns RH, Hix JK: Calciphylaxis from nonuremic causes: A systematic review. Clin J Am Soc Nephrol 2008;3:1139-1143
4. Hayashi M, Takamatsu I, Kanno Y, Yoshida T, Abe T, Sato Y, Japanese Calciphylaxis Study G: A case-control study of calciphylaxis in Japanese end-stage renal disease patients. Nephrol Dial Transplant 2012;27:1580- 1584
5. Au S, Crawford RI: Three-dimensional analysis of a calciphylaxis plaque: Clues to pathogenesis. J Am Acad Dermatol 2002;47:53-57
6. Weenig RH: Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol 2008;58:458-471
7. Rogers NM, Coates PT: Calcific uraemic arteriolopathy: An update. Curr Opin Nephrol Hypertens 2008;17:629-634
8. Hussein MR, Ali HO, Abdulwahed SR, Argoby Y, Tobeigei FH: Calciphylaxis cutis: A case report and review of literature. Exp Mol Pathol 2009;86:134-135
9. Suryadevara M, Schurman SJ, Landas SK, Philip A, Gerlach CB, Tavares T, Souid AK: Systemic calciphylaxis. Pediatr Blood Cancer 2008;51:548-550
10. Mochel MC, Arakaki RY, Wang G, Kroshinsky D, Hoang MP: Cutaneous Calciphylaxis: A Retrospective Histopathologic Evaluation. Am J Dermatopathol 2013; DOI 10.1097/DAD.0b013e31827c7f5d
11. Elamin EM, McDonald AB: Calcifying panniculitis with renal failure: A new management approach. Dermatology 1996;192:156-159
12. Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR: Calciphylaxis: Natural history, risk factor analysis, and outcome. J Am Acad Dermatol 2007;56:569-579
13. Brandenburg VM, Cozzolino M, Ketteler M: Calciphylaxis: A still unmet challenge. J Nephrol 2011;24:142- 148
14. Wu M, Rementer C, Giachelli CM: Vascular Calcification: An Update on Mechanisms and Challenges in Treatment. Calcif Tissue Int 2013; DOI 10.1007/s00223-013-9712-z.
15. Guldbakke KK, Khachemoune A: Calciphylaxis. Int J Dermatol 2007;46:231-238
16. Girotto JA, Harmon JW, Ratner LE, Nicol TL, Wong L, Chen H: Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery 2001;130:645-650; discussion 650-641
17. Lipsker D, Chosidow O, Martinez F, Challier E, Frances C: Low-calcium dialysis in calciphylaxis. Arch Dermatol 1997;133:798-799
18. Monney P, Nguyen QV, Perroud H, Descombes E: Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Nephrol Dial Transplant 2004;19:2130-2132
19. Swanson AM, Desai SR, Jackson JD, Andea AA, Hughey LC: Calciphylaxis associated with chronic inflammatory conditions, immunosuppression therapy, and normal renal function: A report of 2 cases. Arch Dermatol 2009;145:723-725
20. Russell R, Brookshire MA, Zekonis M, Moe SM: Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care. Clin Nephrol 2002;58:238-243
21. Alikadic N, Kovac D, Krasna M, Lindic J, Sabovic M, Tomazic J, Jeras M, Smrke D: Review of calciphylaxis and treatment of a severe case after kidney transplantation with iloprost in combination with hyperbaric oxygen and cultured autologous fibrin-based skin substitutes. Clin Transplant 2009;23:968-974
22. Lal G, Nowell AG, Liao J, Sugg SL, Weigel RJ, Howe JR: Determinants of survival in patients with calciphylaxis: A multivariate analysis. Surgery 2009;146:1028-1034
23. Velasco N, MacGregor MS, Innes A, MacKay IG: Successful treatment of calciphylaxis with cinacalcet-An alternative to parathyroidectomy? Nephrol Dial Transplant 2006;21:1999-2004
24. Sharma A, Burkitt-Wright E, Rustom R: Cinacalcet as an adjunct in the successful treatment of calciphylaxis. Br J Dermatol 2006;155:1295-1297
25. Cicone JS, Petronis JB, Embert CD, Spector DA: Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 2004;43:1104-1108
26. Brucculeri M, Cheigh J, Bauer G, Serur D: Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Semin Dial 2005;18:431-434
27. Yatzidis H: Successful sodium thiosulphate treatment for recurrent calcium urolithiasis. Clin Nephrol 1985;23:63-67
28. Kyriakopoulos G, Kontogianni K: Sodium thiosulfate treatment of tumoral calcinosis in patients with endstage renal disease. Ren Fail 1990;12:213-219
29. Schlieper G, Brandenburg V, Ketteler M, Floege J: Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 2009;5:539-543
30. Zitt E, Konig M, Vychytil A, Auinger M, Wallner M, Lingenhel G, Schilcher G, Rudnicki M, Salmhofer H, Lhotta K: Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients. Nephrol Dial Transplant 2013; DOI 10.1093/ndt/gfs548
31. Farah M, Crawford RI, Levin A, Chan Yan C: Calciphylaxis in the current era: Emerging 'ironic' features? Nephrol Dial Transplant 2011;26:191-195
32. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S: Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 2008;74:1444-1453
33. Roy A, Khan AH, Islam MT, Prieto MC, Majid DS: Interdependency of cystathione gamma-lyase and cystathione beta-synthase in hydrogen sulfide-induced blood pressure regulation in rats. Am J Hypertens 2012;25:74-81
34. Zavaczki E, Jeney V, Agarwal A, Zarjou A, Oros M, Katko M, Varga Z, Balla G, Balla J: Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney Int 2011;80:731- 739
35. Farese S, Stauffer E, Kalicki R, Hildebrandt T, Frey BM, Frey FJ, Uehlinger DE, Pasch A: Sodium thiosulfate pharmacokinetics in hemodialysis patients and healthy volunteers. Clin J Am Soc Nephrol 2011;6:1447- 1455
36. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu- Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG: Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004;350:1516-1525
37. Musso CG, Enz P, Vidal F, Gelman R, Lizarraga A, Giuseppe LD, Kowalczuk A, Garfi L, Galimberti R, Algranati L: Use of sodium thiosulfate in the treatment of calciphylaxis. Saudi J Kidney Dis Transpl 2009;20:1065- 1068
38. Guerra G, Shah RC, Ross EA: Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: Case report. Nephrol Dial Transplant 2005;20:1260-1262
39. O'Neill WC: Treatment of vascular calcification. Kidney Int 2008;74:1376-1378
40. Agroyannis B, Tzanatos H, Vlahakos DV, Mallas E: Does long-term administration of sodium thiosulphate inhibit progression to renal failure in nephrocalcinosis? Nephrol Dial Transplant 2001;16:2443-2444
41. O'Neill WC, Hardcastle KI: The chemistry of thiosulfate and vascular calcification. Nephrol Dial Transplant 2012;27:521-526
42. Araya CE, Fennell RS, Neiberger RE, Dharnidharka VR: Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol 2006;1:1161-1166
43. Sato T, Ichioka S: How should we manage multiple skin ulcers associated with calciphylaxis? J Dermatol 2012;39:966-968
44. Torregrosa JV, Duran CE, Barros X, Blasco M, Arias M, Cases A, Campistol JM: Successful treatment of calcific uraemic arteriolopathy with bisphosphonates. Nefrologia 2012;32:329-334
45. Fine A, Zacharias J: Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy. Kidney Int 2002;61:2210-2217
46. Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, Kasiske BL, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers PW, Agodoa L: Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis 2010;55:S1-420, A426-427
47. Kramar R, Oberbauer R: Austrian dialysis and transplant registry (oedtr), annual report 2012. www. nephro.at, Austrian Society of Nephrology, 2012